PTPI
Petros Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for Petros Pharmaceuticals, Inc. (PTPI), newest first, with AI summaries and stories.
- Ticker
- PTPI
- CIK
- 1815903
- Sector
- Biotech and pharma
- Latest filing
- Sep 30
Next: 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
8-KPetros Pharmaceuticals, Inc.PTPILIVE 10-QPetros Pharmaceuticals, Inc.PTPILIVE 3Petros Pharmaceuticals, Inc.PTPILIVE Robert Weinstein, new insider at PTPI
Robert Weinstein, reporting
8-KPetros Pharmaceuticals, Inc.PTPILIVE 4Petros Pharmaceuticals, Inc.PTPILIVE Wayne Remell Walker, insider filing for PTPI
Wayne Remell Walker, reporting
4Petros Pharmaceuticals, Inc.PTPILIVE 3 insider filings
Fady Boctor, insider filing for PTPI
Show all 3
- 4Insider filing for PTPI
- 4Insider filing for PTPI
- 4Insider filing for PTPI
Fady Boctor, reporting
8-KPetros Pharmaceuticals, Inc.PTPILIVE 10-QPetros Pharmaceuticals, Inc.PTPILIVE 10-KPetros Pharmaceuticals, Inc.PTPILIVE NT 10-KPetros Pharmaceuticals, Inc.PTPILIVE SCHEDULE 13G/APetros Pharmaceuticals, Inc.PTPILIVE Ownership stake disclosure by Iroquois Capital Management, LLC (amended)
Iroquois Capital Management, LLC, filed by
4Petros Pharmaceuticals, Inc.PTPILIVE Fady Boctor, insider filing for PTPI
Fady Boctor, reporting
4Petros Pharmaceuticals, Inc.PTPILIVE 3 insider filings
Joshua Silverman, insider filing for PTPI
Show all 3
- 4Insider filing for PTPI
- 4Insider filing for PTPI
- 4Insider filing for PTPI
Joshua Silverman, reporting
8-KPetros Pharmaceuticals, Inc.PTPILIVE 25-NSEPetros Pharmaceuticals, Inc.PTPILIVE Petros Pharmaceuticals, Inc. filed 25-NSE
- Form Type: 25-NSE
- Filing Date: 2025-11-20
Nasdaq Stock Market LLC, filed by
10-QPetros Pharmaceuticals, Inc.PTPILIVE Petros Pharmaceuticals, Inc. (PTPI) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.
8-KPetros Pharmaceuticals, Inc.PTPILIVE